OSSIO
Taly Lindner has a diverse and extensive work experience. They started their career as an Application Engineer at Applied Materials from September 2002 to October 2005. Following that, Lindner worked as a Ph.D. Candidate at Technion - Israel Institute of Technology from October 2005 to July 2010. After completing their Ph.D., Lindner held consultant roles as a Biomaterial Engineer at BRC from March 2010 to February 2011, and as a Sr. Biomedical Engineer at TheraCell, Inc from September 2010 to May 2011. Lindner then joined the California Institute of Technology as a Biomedical Engineer and Consultant from March 2011 to May 2011, and as a Postdoctoral Scholar in Aerospace, Bio-inspired Design from June 2011 to October 2013.
In 2014, Lindner became the VP Products at Resorbium from June 2014 to August 2015. From September 2015 to November 2016, Lindner worked as the VP R&D and Scientific Affairs at Ossio, Ltd. They then transitioned to the role of VP Scientific and Regulatory Affairs at the same company from November 2016 onwards.
Taly Lindner completed a Bachelor of Science degree in Biomedical Engineering from Technion - Israel Institute of Technology in the years 1999 to 2003. Later, they pursued their education further and obtained a Ph.D. in Biomedical Engineering from the same institution, graduating between the years 2005 and 2010.
This person is not in any offices
OSSIO
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.